GENOMICS LIVE AGENDA

 

DOWNLOAD AGENDA

 

Basel, 4 - 5 December 2019

Schedule

Create your personal agenda –check the favourite icon

Dec 408:40
Conference pass
Dec 409:00
Conference pass

Is Precision Medicine delivering on its promises?

Keynotes
Dec 409:40
Conference pass

Simultaneous multi-cancer detection and tissue of origin localization using targeted bisulfite sequencing of plasma cell-free DNA

Keynotes
Dec 410:20
Conference pass

Accelerating Drug Development Using CtDNA

Keynotes
Dec 411:40
Conference pass

Roundtables

Keynotes
"Tissunomics" - how to integrate clinical and molecular data in tissue diagnostics
Santiago Ramon Y Cajal, Chairman Of Pathology Department, Vall Dhebron Barcelona Hospital Campus
Best preparations for CTC liquid biopsies
Pamela Pinzani, Associate Professor, University of Florence
Commercial Diagnostic strategy in a changing diagnostic landscape
Jens Klabunde, Diagnostics Strategy Leader, Personalized Healthcare, Roche
Epigenetics: drivers or passengers in transcription regulation and disease etiology
How to integrate liquid biopsies into routine care
Immuno-oncology Biomarkers
Philip Jermann, Head of Molecular Assay Development Unit, University Hospital Basel
Integrating Genomics into routine clinical trials
Making Digital Pathology Data Mineable
Pierre Moulin, Global Head Of Pathways And Molecular Pathology, Novartis International AG
Dec 413:30
Conference pass
Dec 413:30
Conference pass

Chair's Remarks

Circulating Tumour DNA & Liquid Biopsy
Dec 413:30
Conference pass

Chair's Remarks

Immuno-Oncology & Companion Diagnostics
Dec 413:30
Conference pass
Dec 413:35
Conference pass

Predicting Breast Cancer Survival using Digital Pathology

Digital Pathology
Fabien Gaire, Global Head Of Pathology And Tissue Analytics, roche
Dec 413:35
Conference pass
Dec 413:35
Conference pass

Requirements for successful application of diagnostics in the context of precision medicine

Immuno-Oncology & Companion Diagnostics
Dec 413:35
Conference pass

Molecular Diagnostic Informational Management Systems

Biobanking & Tissue Management
Dec 413:55
Conference pass

Sponsor Presentation

Digital Pathology
Dec 413:55
Conference pass

The TLA Technology & complete gene sequencing for precision cancer medicine

Circulating Tumour DNA & Liquid Biopsy
Dec 414:15
Conference pass

Computational Pathology – integrating data mining into routine clinical practice

Digital Pathology
Dec 414:15
Conference pass
Dec 414:15
Conference pass

Genomic Profiling in Immunotherapy response

Immuno-Oncology & Companion Diagnostics
Dec 414:15
Conference pass

Implementation of a genomics service into a National Healthcare system- a regional approach

Biobanking & Tissue Management
Dec 415:05
Conference pass

Chair's Remarks

Digital Pathology
George Lee, Digital pathology Informatics Lead/ Data Scientist, Bristol Myers Squibb
Dec 415:05
Conference pass

Chair's Remarks

Circulating Tumour DNA & Liquid Biopsy
Dec 415:05
Conference pass

Chair's Remarks

Immuno-Oncology & Companion Diagnostics
Dec 415:05
Conference pass
Dec 415:10
Conference pass

Diving deep into tissue: Unleashing it's potential for biomarker R&D using digital image analysis

Digital Pathology
Dec 415:10
Conference pass

Novel digital PCR and mutation enrichment technologies for detecting minimal residual disease and monitoring in liquid biopsies

Circulating Tumour DNA & Liquid Biopsy
Dec 415:10
Conference pass

Translating Genomics in Immuno-oncology

Immuno-Oncology & Companion Diagnostics
Dec 415:10
Conference pass

Genomics in LIFE - Experiences from the Leipzig Research Center for Civilisation Diseases (LIFE)

Biobanking & Tissue Management
Dec 415:30
Conference pass

Organizing your Repertoire Sequencing data using the IGX Platform

Circulating Tumour DNA & Liquid Biopsy
Jos Lunenberg, Chief Executive Officer, ENPICOM
Dec 415:50
Conference pass
Dec 415:50
Conference pass

Detection, Characterization and ex vivo Expansion of Viable Circulating Tumour Cells (CTCs)

Circulating Tumour DNA & Liquid Biopsy
Dec 415:50
Conference pass

Clinical relevance of intrinsic subtyping of breast cancer: from PAM50 to Prosigna ®

Immuno-Oncology & Companion Diagnostics
Maggie Cheang, Team Leader, Genomic Analysis – Clinical Trials, Institute of Cancer Research
Dec 415:50
Conference pass

Infrastructures for precision medicine research: Biobanking at a global scale

Biobanking & Tissue Management
Dec 416:50
Conference pass

Chair's Remarks

Digital Pathology
Pierre Moulin, Global Head Of Pathways And Molecular Pathology, Novartis International AG
Dec 416:50
Conference pass

Chair's Remarks

Circulating Tumour DNA & Liquid Biopsy
Janet Jin, Director, Clinical Biomarkers And Cdx, AbbVie
Dec 416:50
Conference pass

Chair's Remarks

Immuno-Oncology & Companion Diagnostics
Rhoda Molife, Senior Clinical Director, MSD
Dec 416:50
Conference pass
Dec 417:15
Conference pass

Quantification issues in tissue samples: using histology to support clinically relevant biomarkers

Digital Pathology
Dec 417:15
Conference pass

Presentation reserved for FNIH

Circulating Tumour DNA & Liquid Biopsy
Vali Papadimitrakopoulou, Professor Of Medicine And Chief Thoracic Medical Oncology, National Leader Lung-Map, The University of Texas MD Anderson Cancer Center
Dec 417:15
Conference pass

Moving towards an Integrative diagnostic immuno-oncology platform

Immuno-Oncology & Companion Diagnostics
Dec 417:15
Conference pass

Scottish Population Research Biobanks – balancing use, ethics and access to genetic results

Biobanking & Tissue Management
Dec 417:55
Conference pass

Label-free digital pathology provides automated tissue classification without inter observer variability

Digital Pathology
Klaus Gerwert, Professor, Ruhr University Bochum
Dec 417:55
Conference pass

Value proposition for advanced molecular diagnostics in non-small cell lung cancer

Circulating Tumour DNA & Liquid Biopsy
Dec 417:55
Conference pass

Avoiding the Biomarker graveyard-  Jumping the valley of death between academia and industry

Immuno-Oncology & Companion Diagnostics
Dec 417:55
Conference pass

Working towards a fully automated liquid biobank

Biobanking & Tissue Management

Create your personal agenda –check the favourite icon

Dec 509:00
Conference pass

Developing Biomarkers for an NTRK Inhibitor in a tissue agnostic indication

Keynotes
Dec 510:20
Conference pass

The Yin and Yang of Precision Medicine

Keynotes
Stefan Scherer, Vice President Global Head Experimental Medicine, GlaxoSmithKline
Dec 510:40
Conference pass

Challenges and Opportunities for Biomarkers in Early Clinical Development

Keynotes
Bruno Gomes, Global Head Of Biomarkers Oncology, Roche
Dec 511:40
Conference pass

Roundtables

Keynotes
Best practice for analytical techniques to improve precision medicine
Markus Paulmichl, Chair Of Department Of Personalised Medicine, Humanomed
Current technologies and future challenges in single cell research
From targeting tumor mutations to finding cancer predisposition genes: the other side of the coin
How can academics and industry work together to turn basic science into better patient outcomes
How can we obtain the maximum information from liquid biopsies and translate it to the clinic?
Lorena Dieguez, Group Head, Nano4Health Unit, International Iberian nanotechnology laboratory
Overcoming the challenges of implementing genomics in healthcare
Rolf Apweiler, Embl-Ebi Director, EMBL- EBI
Overcoming the challenges of precision medicine using a regional genomics programme
Pascal Pujol, Head Of Cancer Genetics Department, C.H.U. Montpellier
Pre-clinical Biomarkers - overcoming the challenges of const belefit in genomic biomarker strategies
Tim Roloff, Lab Head, Genomics Platform, Idorsia Pharmaceuticals
Single Cell Analysis---Clinical purposes and methods: from dissociation to comprehensive analysis of single cells
Dec 513:30
Conference pass
Dec 513:30
Conference pass

Chair's Remarks

Flow Cytometry & Single Cell Analysis
Dec 513:30
Conference pass
Dec 513:35
Conference pass

Integrated omics for mapping the human proteome in health and disease

Molecular Diagnostics
Cecilia Lindskog, Director Human Tissue Atlas, Uppsala University
Dec 513:35
Conference pass
Dec 513:35
Conference pass

Precision Medicine in Melanoma

Precision Medicine
Dec 513:55
Conference pass

Precision Medicine in Pfizer’s Early Clinical Portfolio

Precision Medicine
Dec 514:15
Conference pass

Development of an integrated platform for biomarker and drug target discovery using proteomics

Molecular Diagnostics
Tony Whetton, Director, Stoller Biomarker Discovery Centre
Dec 514:15
Conference pass

Coordinating molecular testing and patient stratification within a national health care system

Cancer Diagnostics
Dec 514:15
Conference pass

Benchmarking single-cell sequencing technologies for drug discovery applications

Flow Cytometry & Single Cell Analysis
Dec 514:15
Conference pass

Presentation by CytoReason

Precision Medicine
Shai Shen-Orr, Chief Scientist, CytoReason
Dec 515:15
Conference pass
Dec 515:15
Conference pass

Chair's Remarks

Flow Cytometry & Single Cell Analysis
Corinne Solier, Global Head BiOmics&Pathology, Roche Pharma
Dec 515:15
Conference pass

Chair's Remarks

Precision Medicine
Eike Staub, Director, Head of Oncology Bioinformatics, Merck Group
Dec 515:20
Conference pass

The bridge between the Genomic and Proteomic fingerprint in response to treatment

Molecular Diagnostics
Mike Baratta, Scientific Director, Chief Of Staff And Clinical Biomarker Development And Innovation, Takeda Pharmaceuticals International GmbH (Vaccines)
Dec 515:20
Conference pass
Dec 515:20
Conference pass
Dec 515:20
Conference pass

Non-Invasive Prenatal Screening (NIPS) based on Limited Template

Flow Cytometry & Single Cell Analysis
Michael Sinosich, Scientific Director, Prenatal Testing, Sonic Healthcare Ltd
Dec 515:40
Conference pass

Single Cell RNA-Seq Data Analysis Made Simple

Flow Cytometry & Single Cell Analysis
Dec 516:00
Conference pass

Personalized medicine; more than planning, doing

Molecular Diagnostics
Dec 516:00
Conference pass

Clinical Application of Molecular Tumor Profiling for Best Oncology Care

Cancer Diagnostics
Dec 516:00
Conference pass

Mining the cancer cell surfaceome for therapeutic applications

Flow Cytometry & Single Cell Analysis
Dec 516:00
Conference pass

Transitioning complex cancer genomics into routine oncology practice

Precision Medicine
Dec 517:00
Conference pass

Chair's Remarks

Cancer Diagnostics
Wolfgang Hackl, Founder, OncoGenomX
Dec 517:05
Conference pass

MiRNAs as a diagnostic tool to predict Blood Brain Barrier impairment

Molecular Diagnostics
Dec 517:05
Conference pass

Cancer genomics portfolio for diagnostics, clinical trials and translational research in the Stockholm healthcare region

Cancer Diagnostics
Dec 517:05
Conference pass

Two decades of pharmacogenetics research at GSK: patient impacts and future directions

Precision Medicine
Charles Cox, Head Of Pharmacogenetics, Genetics, Target Sciences, G.S.K. R and D
Dec 517:05
Conference pass

Using SERS and microdroplets for analysis of single tumor cells

Flow Cytometry & Single Cell Analysis
Lorena Dieguez, Group Head, Nano4Health Unit, International Iberian nanotechnology laboratory
Dec 517:45
Conference pass

Molecular Pathology in the Netherlands

Molecular Diagnostics
Ed Schuuring, Professor In Molecular Oncological Pathology, University of Groningen
Dec 517:45
Conference pass

WHO International Standards for Cancer Genomic Diagnostics

Cancer Diagnostics
Dec 517:45
Conference pass

Perspectives from a core facility

Flow Cytometry & Single Cell Analysis
Ulrich Kadolsky, Senior Bioinformatician, GSTT And KCL BRC Genomics Research Platform
Dec 517:45
Conference pass
last published: 09/Oct/19 16:15 GMT

 

Contact us

To sponsor or exhibit contact:
Harry Ludbrook
+44 (0)207 092 1049

Harry.Ludbrook@terrapinn.com


To speak:
Diana Georgi
+44 (0)20 7092 1075

Diana.georgi@terrapinn.com